Combined Global Demand Forecasts for Antiretroviral Medicines and HIV Diagnostics in Low- and Middle-Income Countries from 2015 to 2020

The number of people receiving antiretroviral therapy (ART) in low- and middle-income countries continues to show promising growth, indicating that the global effort to scale up HIV treatment has exceeded 15 million people by the end of 2015. As of the end of 2015, the number of people receiving ART had reached 15.9 million in low- and middle-income countries, indicating a stable annual growth rate of 1.8 million per year since 2012.

The goal of this report is to provide countries and suppliers with estimates of the global market for antiretroviral (ARV) medicines in low- and middle-income countries for 2015–2020. The report includes estimates of the global demand for both active pharmaceutical ingredients and ARV formulations to enable suppliers to manage their manufacturing capacity accordingly.